TB-500 is a synthetic analog of a naturally occurring 43-amino-acid peptide fragment of Thymosin Beta-4. While BPC-157 is the more well-known healing peptide, TB-500 addresses a fundamentally different aspect of tissue repair — the cytoskeleton.
Actin: The Scaffolding of Cell Movement
Actin is the most abundant protein in most eukaryotic cells. It forms microfilaments — thin, flexible fibers that create the cell's internal framework. When tissue is damaged, repair cells (fibroblasts, endothelial cells, stem cells) must migrate to the injury site. This movement depends entirely on actin polymerization.
TB-500's primary mechanism is actin sequestration — it binds to G-actin (monomeric actin) and maintains a pool of available actin monomers. When cell migration signals are activated, TB-500 releases actin, allowing rapid cytoskeletal reorganization and cell movement.
Preclinical Evidence
- Dermal wound healing: Philp et al. (2003) showed TB4 accelerates wound closure in rat full-thickness skin wounds by 40% vs controls, primarily through enhanced keratinocyte migration.
- Cardiac repair: Bock-Marquette et al. (2004) demonstrated TB4 promotes cardiac cell migration and survival after myocardial infarction in mice.
- Tendon and ligament: Xu et al. (2013) found TB4 upregulates tenocyte proliferation and collagen I production in vitro.
BPC-157 + TB-500: Why They're Studied Together
BPC-157 stimulates blood vessel formation and growth factor signaling at the repair site. TB-500 enables the cells that respond to those signals to actually reach the site. The two peptides address complementary bottlenecks in the healing cascade:
- BPC-157: "build new blood vessels and amplify repair signals"
- TB-500: "enable cells to migrate to where the signals are coming from"
This is why the "recovery stack" combining both peptides is one of the most researched combinations in the peptide space.
For research use only. Not for human consumption.